NRG Oncology; Clinical Trial Development Division; Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY.

NRG Oncology SDMC, CTD Division, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address:

Roswell Park Cancer Institute, Buffalo, NY;

From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C., K.B.-E.); Women's Cancer Center of Nevada, Las Vegas (N.M.S.); NRG Oncology Statistical and Data Management Center, Roswell Park Cancer Institute, Buffalo (D.E., H.Q.H., M.F.B.), and Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (P.S.) - both in New York; the University of Cincinnati, University of Cincinnati Cancer Institute, Cincinnati (T.J.H.); the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore (D.K.A.); Seoul National University College of Medicine (J.-W.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine (B.-G.K.), and Asan Medical Center, University of Ulsan College of Medicine (J.-H.N.), Seoul, and the Research Institute and Hospital, National Cancer Center, Goyang (S.-Y.P.) - all in South Korea; Saitama Medical University International Medical Center, Hidaka, Japan (K.F.); the University of Oklahoma Health Sciences Center, Oklahoma City (J.L.W., R.S.M.); National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, U.S. Oncology Research, and Metro-Minnesota Community Oncology Research Consortium, Minneapolis (A.C.C.); Duke Cancer Institute, Duke University Medical Center, Durham, NC (A.A.S.); Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.R.); Gynecologic Cancer Program, California Pacific-Palo Alto Medical Foundation, Sutter Research Institute, San Francisco (J.K.C.); Women and Infants Hospital, Providence, RI (P.D.); the University of Colorado School of Medicine, Aurora, and Denver Health Medical Center, Denver (S.A.D.); Ohio State University, Columbus (D.E.C.); and the University of California, Irvine, Orange (K.S.T.).

NRG Oncology Statistical and Data Center, Roswell Park Cancer Institute, University of Buffalo, Buffalo, NY, USA

2 Roswell Park Cancer Institute, Buffalo, NY.

NRG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY;

GOG Foundation Statistical and Data Center, Roswell Park Cancer Institute, Buffalo.

The NRG Oncology Statistical and Data Center, Roswell Park Cancer Center Institute, Buffalo, New York.

University of Buffalo, Buffalo, NY, USA

Statistical Office, NRG Oncology, Buffalo, New York

From the California Pacific-Palo Alto Medical Foundation, Sutter Cancer Research Institute, San Francisco (J.K.C.); NRG Oncology-Gynecologic Oncology Group Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY (M.F.B., H.H.); Massachusetts General Hospital, Boston (R.T.P., M.J.B.); University of Oklahoma, Oklahoma City (J.L.W.); Women and Infants Hospital, Providence, RI (P.A.D.S.); University of Pennsylvania (S.C.R.) and Fox Chase Cancer Center (L.P.M.) - both in Philadelphia; University of Colorado Cancer Center, Aurora (S.A.D.); University of Alabama at Birmingham, Birmingham (W.K.H.); James Cancer Center, Ohio State University, Columbus (D.M.O.); Minnesota Oncology/Hematology-Oncology Service, Edina (M.P.B.); Indiana University School of Medicine, Carmel (H.M.); and University of Arizona Cancer Center, Creighton University School of Medicine, and St. Joseph's Hospital and Medical Center (B.J.M.) - all in Phoenix.

NRG Oncology Statistical Office, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, United States

GOG Statistical and Data Center, Buffalo, NY

Gynecology Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Elm and Carlton Streets, 14221, Buffalo, NY, USA

Roswell Park Cancer Institute, Buffalo, NY

The Fox Chase Cancer Center, Philadelphia; The Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; The Arizona Cancer Center, Tucson; The University of Chicago, Chicago; Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Phoenix, AZ; The University of Oklahoma Health Sciences Center, Oklahoma City; Wake Forest University School of Medicine, Winston-Salem, NC; James Cancer Hospital at Ohio State University, Hilliard; Seattle Cancer Care Alliance, Seattle; Minnesota Oncology and Hematology, Minneapolis; Harvard Medical School and Massachusetts General Hospital, Boston; and North Shore–Long Island Jewish Health System, New Hyde Park, NY

Gynecologic Oncology Group Statistical & Data Center, Roswell Park Cancer Institute, Buffalo, NY 14263-0001, USA

*National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), Kingston, Ontario, Canada; †Gynecologic Oncology Group (GOG), Philadelphia, PA; ‡AGO-OVAR-Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom, Wiesbaden, Germany; §Université Paris Descartes, AP-HP, Hôpital Hôtel-Dieu, Paris, France; ∥Medical Research Council, London, UK; ¶Scottish Gynaecological Cancer Trials Group, Glasgow, UK; and **IEO-Istituto Europeo di Oncologia, Milan, Italy.

Fox Chase Cancer Center, Philadelphia, PA; Gynecologic Oncology Group, Buffalo, NY; Arizona Cancer Center, Tucson, AZ; University of Oklahoma Health Sciences Center, Oklahoma City, OK; The Brody School of Medicine, Greenville, NC; James Cancer Hospital, The Ohio State University, Hilliard, OH; University of California, Irvine Medical Center, Orange, CA; Seattle Cancer Care Alliance, Seattle, WA; Minnesota Oncology and Hematology, Minneapolis, MN; Stony Brook University, Stony Brook, NY

Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York

University of Minnesota School of Medicine, Minneapolis, MN

From the Fox Chase Cancer Center, Philadelphia, PA

SUNY Buffalo, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY

Franklin Square Hospital

Baltimore, MD

Affiliations of authors: MRC Clinical Trials Unit, London, UK (MKBP, MS, RL, RK, AMS, WQ, PR); Institute of Psychiatry, King’s College London, London, UK (FMSB); NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada (EE); School of Public Health and Health Professions, University at Buffalo, Buffalo, NY (MB); CR-UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (NJ); Fox Chase Cancer Center, Philadelphia, PA (MAB)

Gynecologic Oncology Group Statistical Center, Buffalo, NY

From the Division of Solid Tumor Oncology, Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

University of Arizona Cancer Center, Tucson, AZ

and the M.D. Anderson Cancer Center, Houston, TX

Vanderbilt University Medical Center, Nashville, TN

Fred Hutchinson Cancer Research Center, Seattle, WA; Arizona Cancer Center, Tucson, AZ; University of California Irvine, Irvine, CA; GOG Statistical and Data Center, Buffalo, NY; M. D. Anderson Cancer Center, Houston, TX

Southwest Oncology Group Statistical Office, Seattle, WA

MetroHealth Medical Center, Cleveland, OH; Tufts-New England Medical Center, Hartford, CT; Gynecology Oncology Group, Buffalo, NY; Duke University Medical center, Durham, NC; Medical Center of Pennsylvania, Hershey, PA; University of Pennsylvania, Philadelphia, PA; Indiana University School of Medicine, Indianapolis, IN; Presbyterian St. Lukes Hospital, Chicago, IL

From the Division of Oncology, Department of Medicine, University of Mississippi School of Medicine, Jackson, MS

and Department of Pathology, University of California at Irvine, Orange, CA

Wake Forest University School of Medicine, Winston-Salem, NC

From the Fox Chase Cancer Center, Philadelphia, PA; Roswell Park Cancer Institute, Buffalo, NY; University of California Los Angeles Medical Center, Los Angeles, CA, Mayo Comprehensive Cancer Center, Rochester, MN; Walter Reed Army Medical Center, Washington, DC; Wake Forest University School of Medicine, Winston-Salem, NC; Indiana University School of Medicine, Indianapolis, IN; and the University of Arizona College of Medicine and Arizona Cancer Center, Tucson, AZ.

Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, 14263

From the Department of Medicine, Washington University School of Medicine, St Louis, MO; Gynecologic Oncology Group, Roswell Park Cancer Institute, Buffalo, NY; Department of Obstetrics and Gynecology, Indiana University Medical Center, Indianapolis, IN; Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences, Oklahoma City, OK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Case Western Reserve University, University...

Gynecologic Oncology Group, Roswell Park Cancer Institute, Buffalo, New York, 14263

From the Departments of Medicine and Medical OncologyKaplan Cancer Center, New York University, New York; and Roswell Park Cancer Institute, Buffalo, NY; Department of Obstetrics and Gynecology, Louisiana State University Medical Center, New Orleans, LA; Division of Gynecologic Oncology, Indiana University Medical School, Indianapolis, IN; Department of Pathology, Columbus Cancer Council, James Cancer Hospital, Ohio State University, Columbus, OH; Section on Gynecologic Oncology, Wake Forest University...

GOG Statistical Office, Roswell Park Cancer Institute, Buffalo, USA.

From the Division of Oncology, University of Mississippi School of Medicine, Jackson, MS; Gynecologic Oncology Group, Roswell Park Cancer Institute, Buffalo, and Comprehensive Gynecology, Crouse Irving Memorial Hospital, Syracuse, NY; Department of Gynecologic Oncology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL; Bowman Gray School of Medicine, Carolina Gynecologic Oncology, Winston-Salem, and Division of Gynecologic Oncology, Department of Obstetrics and...

Gynecologic Oncology Group Statistical Office, Roswell Park Cancer Center, Buffalo,

Gynecologic Oncology Group Statistical Office, Roswell Park Cancer Institute, Buffalo, N.Y. (M.F.B.)

New York and Buffalo, New York, Baltimore, Maryland, Winston-Salem, North Carolina, Charleston, South Carolina, Irvine and Los Angeles, California, and Boston, Massachusetts

GOG Administrative Office, Suite 1945, 1234 Market Street, Philadelphia, PA 19107

University of Colorado School of Medicine and the Gynecology Tumor Service, St. Luke's Hospital, Denver, Colorado

Roswell Park Cancer Institute, Buffalo, New York

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology (D.S.M.), University of Texas Southwestern Medical School, Dallas, Texas; Gynecologic Oncology Group (M.F.B.), Roswell Park Memorial Institute, Buffalo, New York; Department of Obstetrics and Gynecology, Section on Gynecologic Oncology (R.J.B.), Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina, U.S.A.

From the Department of Anatomic Pathology (T.K., S.G.S.), George Washington University Medical Center, Washington, D.C.; The Milton S. Hershey Medical Center of the Pennsylvania State University (T.K.), Hershey, Pennsylvania; the Department of Obstetrics and Gynecology, University of Colorado School of Medicine, and Gynecology Tumor Service (F.J.M.), St. Luke's Hospital, Denver, Colorado; the Department of Pathology (A.M.), Rush-Presbyterian St. Luke's Medical Center, Chicago, Illinois; the Department of Pathology (B.F.), Duke University Medical Center, Durham, North Carolina; and the Gynecologic Oncology Group (M.F.B.), Roswell Park Cancer Institute, Buffalo, New York.

Gynecological Oncology Group, Philadelphia, Pennsylvania

Gynecologic Oncology Group, Cancer Research Scientist, Roswell Park Memorial Institute, Buffalo, New YorkU.S.A.

National Prostatic Cancer Project, Roswell Park Memorial Institute, Buffalo, New York